IMRX
#3260
Immuneering Corporation - Class A Common Stock
4.9 9 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.22%
Variación mensual
+16.59%
Variación en los últimos 6 meses
+2.89%
Cambio anual
-11.52%
Cierres anteriores
5.2 1
Open
4.9 9
Mínimo
4.9 9
Máximo
4.9 9
Volumen
41
Financials
- Market Capitalization 322.84 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3218 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.92 USD | -1.99% | -3.43% | -9.06% | -13.45% | 338.53 M USD | ||
| 3222 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +6.17% | +36.16% | 336.28 M USD | ||
| 3265 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.29 USD | -2.76% | -0.94% | +2.52% | -4.34% | 319.85 M USD | ||
| 3293 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +30.40% | +92.22% | 311.95 M USD |